 <h1>Motegrity Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>prucalopride</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about prucalopride. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Motegrity.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to prucalopride: oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, prucalopride (the active ingredient contained in Motegrity) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking prucalopride:</p><p>
<i>Less common</i>
</p><ul>
<li>Frequent urination of small amounts of urine in the daytime</li>
<li>headache, severe and throbbing</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Chest pain or discomfort</li>
<li>confusion</li>
<li>difficulty in speaking</li>
<li>double vision</li>
<li>headache</li>
<li>inability to move the arms, legs, or facial muscles</li>
<li>inability to speak</li>
<li>nausea</li>
<li>pain or discomfort in the arms, jaw, back, or neck</li>
<li>slow speech</li>
<li>sweating</li>
<li>thoughts or attempts at killing oneself</li>
<li>troubled breathing</li>
<li>vomiting</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Hives or welts, itching, skin rash</li>
<li>redness of the skin</li>
<li>swelling of the face</li>
<li>tightness in the chest</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of prucalopride may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Diarrhea</li>
<li>stomach pain</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Abnormal stomach or bowel sounds</li>
<li>bloated or full feeling</li>
<li>decreased appetite</li>
<li>dizziness</li>
<li>excess air or gas in the stomach or bowels</li>
<li>passing gas</li>
<li>stomach distension</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to prucalopride: oral tablet</i></p><h3>General</h3><p>The most commonly reported side effects included headache, abdominal pain, nausea, and diarrhea.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Diarrhea occurred within the first week in 70% of those reporting the side effect, and usually resolved within a few days in 73% of the patients.  Severe diarrhea occurred in approximately 1.3% of patients.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Nausea (up to 19.6%), Abdominal pain (up to 16%), diarrhea (up to 13%)</p>
<p><b>Common</b> (1% to 10%): Abdominal distention, abnormal bowel sounds, abnormal gastrointestinal sounds, dyspepsia, flatulence, rectal hemorrhage, upper abdominal pain, vomiting</p>
<p><b>Uncommon</b> (0.1% to 1%): </p>
<p><b>Frequency not reported</b>: Abdominal discomfort, abdominal tenderness, epigastric discomfort, lower abdominal pain<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 24.2%)</p>
<p><b>Common</b> (1% to 10%): Dizziness</p>
<p><b>Uncommon</b> (0.1% to 1%): Tremors</p>
<p><b>Frequency not reported</b>: Migraine<sup>[Ref]</sup></p><p>Headache occurred within the first 2 days in 66% of patients who reported the side effect, and usually resolved within a few days in 65% of the patients.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Nasopharyngitis, sinusitis</p>
<p><b>Postmarketing reports</b>: Dyspnea<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue</p>
<p><b>Uncommon</b> (0.1% to 1%): Fever/pyrexia, malaise<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Decreased appetite</p>
<p><b>Uncommon</b> (0.1% to 1%): Anorexia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Influenza<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Palpitations<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Postmarketing reports</b>: Facial edema, pruritus, rash, urticaria<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Polyuria, urinary tract infection</p>
<p><b>Uncommon</b> (0.1% to 1%): Pollakiuria<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. "Product Information. Resotran (prucalopride)." Janssen Pharmaceuticals, Titusville, NJ. </p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>What type of drug is Motegrity?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Motegrity (prucalopride)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>24 Reviews</li>
<li>Drug class: serotoninergic neuroenteric modulators</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Motegrity &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Chronic Idiopathic Constipation</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to prucalopride: oral tablet</i></p><h3>General</h3><p>The most commonly reported side effects included headache, abdominal pain, nausea, and diarrhea.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Diarrhea occurred within the first week in 70% of those reporting the side effect, and usually resolved within a few days in 73% of the patients.  Severe diarrhea occurred in approximately 1.3% of patients.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Nausea (up to 19.6%), Abdominal pain (up to 16%), diarrhea (up to 13%)</p><p><b>Common</b> (1% to 10%): Abdominal distention, abnormal bowel sounds, abnormal gastrointestinal sounds, dyspepsia, flatulence, rectal hemorrhage, upper abdominal pain, vomiting</p><p><b>Uncommon</b> (0.1% to 1%): </p><p><b>Frequency not reported</b>: Abdominal discomfort, abdominal tenderness, epigastric discomfort, lower abdominal pain<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 24.2%)</p><p><b>Common</b> (1% to 10%): Dizziness</p><p><b>Uncommon</b> (0.1% to 1%): Tremors</p><p><b>Frequency not reported</b>: Migraine<sup>[Ref]</sup></p><p>Headache occurred within the first 2 days in 66% of patients who reported the side effect, and usually resolved within a few days in 65% of the patients.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Nasopharyngitis, sinusitis</p><p><b>Postmarketing reports</b>: Dyspnea<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue</p><p><b>Uncommon</b> (0.1% to 1%): Fever/pyrexia, malaise<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Decreased appetite</p><p><b>Uncommon</b> (0.1% to 1%): Anorexia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Influenza<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Palpitations<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Postmarketing reports</b>: Facial edema, pruritus, rash, urticaria<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Polyuria, urinary tract infection</p><p><b>Uncommon</b> (0.1% to 1%): Pollakiuria<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. "Product Information. Resotran (prucalopride)." Janssen Pharmaceuticals, Titusville, NJ. </p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>What type of drug is Motegrity?</li>
</ul><h2>More about Motegrity (prucalopride)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>24 Reviews</li>
<li>Drug class: serotoninergic neuroenteric modulators</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Motegrity &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Chronic Idiopathic Constipation</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>